drugset / Trial / NCT00978367
Investigation of the Safety, Dosing Frequency and Anti-Scarring Potential of Two Concentrations of Intradermal Avotermin (Juvista)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to investigate the dosing frequency, wound healing (re-epithelialisation) and anti-scarring effects of one, three and five applications of two concentrations of intradermal RN1001 in healthy male subjects.
Timeline
- Start
- 2002-02
- Primary completion
- 2002-11
- Completion
- 2002-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Avotermin | Protein / enzyme biologic | 5 ng | Intrathecal |
| Subject | Avotermin | Protein / enzyme biologic | 50 ng | Intrathecal |
Indications
No indication recorded.